维普中文期刊产品整合服务
21篇 您的检索式:作者名="Gabizon R"
    题名 作者 年代 出处 被引量
1On the biology of pri- ons显示文摘Prusiner SB Gabizon R McKinley MP 1987Acta Neuropathol1987,72,4:1
2Doppel and PrP(C) do not share the same membrane microenvironment显示文摘Shaked Y Hijazi N Gabizon R 2002FEBS Lett2002,530,13:1
3Clinical pharmacology of liposomal anthracyclines: focus on pegylated li- posomal doxorubicin 显示文摘SOLOMAN R GABIZON A A 2008Clin Lymphoma Myeloma2008,8,1:1
4Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes显示文摘Gabizon A Catane R Uziely B 1994Cancer Res1994,54,4:1
5显示文摘Gabizon A Goren D Cohen R 1998J Control Release1998,53,13:1
6On the biology of prions显示文摘Prusiner S B Gabizon R McKinley M P 1987Acta Neuropathol (Berl)1987,72,4:1
7Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times显示文摘Gabizon A Shiota R Papahadjopoulos D 1989J Natl Cancer Inst1989,81,:1
8On the biol- ogy of prions显示文摘PRUSINER S B GABIZON R MCKINLEY M P 1987Acta Neuropatho11987,72,:1
9Doppel and PrPc do notshare the same membrane microenvironment显示文摘SHAKED Y HIJAZI N GABIZON R 2002FEBS Lett2002,530,13:1
10Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethyleneglycol coated liposomes显示文摘GABIZON A CATANE R UZIELY B 1994Cancer Research1994,54,:1
11Pharmacoki- netics of pegylated liposomal doxorubicin: review of animal and human studies显示文摘GABIZON A SHMEEDA H BARENHOLZ S R 2003Clin Pharmacokinet2003,42,5:1
12Prolinged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes 显示文摘GABIZON A CATANE R UZIELY B 1994Cancer Res1994,54,4:1
13Immunoaffinity purification and neutralization of scrapie prion infectivity显示文摘Gabizon R 0,,:1
14Purified prion proteins and scrapie infectivity copartition into liposomes显示文摘Gabizon R McKINLEY M Prusiner S 1987Proc Natl Acad Sci USA1987,84,12:1
15Prolonged circulation time and enhanced accumulation in malignant exudate of doxorubicin encapsulated in polyethylene-glycol coated liposomes (DOXIL) 显示文摘Gabizon A Catane R Uziely B 1994Cancer Res1994,54,4:1
16Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes 显示文摘GABIZON A CATANE R UZIELY B 1994Cancer Res1994,54,4:1
17Prolonged circulation time and enhancedaccumulation in malignant exudates of doxorubicin encapsulated in polyethyleneglycolcoated liposomes 显示文摘Gabizon A Catane R Uziely B 1994Cancer Res1994,54,4:1
18Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes显示文摘Gabizon A Catane R Uziely B 0,,04:1
19Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg·m-2 显示文摘 Muggia F Jeffers S Tsao-wei DD Groshen S Lyass O Henderson R Berry G Gabizon A 2000Ann Oncol2000,11,8:1
20Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes显示文摘 Catane R Uziely R 1994Cancer Res1994,54,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费